New digital platform and MicroScan transducers offer unprecedented imaging capabilities including color doppler and cardiac strain analysis. Toronto, Ontario – October 7, 2008 -  The Vevo 2100 was released for sale in the preclinical market today in North …

Dr. Stuart Foster Wins Ernest C. Manning Awards Foundation’s “Award of Distinction” for Development and Commercialization of Preclinical Micro-Ultrasound Calgary, Alberta– September 29, 2006 – In recognition of his innovative concept of micro-ultrasound …

VisualSonics Inc., the leading manufacturer of high-resolution micro-ultrasound systems, was profiled in the September 2006 issue of Genetic Engineering News (www.genengnews.com). VISUALSONICS TARGETS THE PRECLINICAL ARENA By Carol Potera VisualSonics, …

Manufacturing and Technology Collaboration Will Leverage Annual $500 Million Market Toronto, Canada / Geneva, Switzerland - June 7, 2006 - VisualSonics (Toronto), the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging …

Numerous World Renowned Experts Presenting Novel Applications of In Vivo Imaging Using Micro-Ultrasound for Cancer Research Toronto, Ontario. – March 30, 2006 – VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo …

Company Sells 200th System and Continues To Grow at Compounded Annual Rate of 145% Over Past Three Years Toronto, Ontario. – February 8, 2006 – VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging …

International Agreement Licenses Seno's Opto-Acoustic Imaging Technology To VisualSonics to Enable Molecular Imaging at the Cellular Level and Aid in the Pursuit of Neurology, Regenerative Medicine, Inflammation, and Cancer Applications Toronto, Ontario …

(ALEXANDRIA, VA) April 29, 2008 – Oxford Finance Corporation, the principal lender, and Comerica Bank, today announced they have finalized a $15 million senior secured loan agreement with VisualSonics Inc. Both financial institutions are established …

Vevo 770® recognized for its utility, broad range of applications and its total value proposition for preclinical research and drug development Toronto, Ontario – March 16, 2007 – VisualSonics has been awarded the Best Customer Value” Award by Frost & …

Advanced Cardiovascular Functionality Provides Researchers with Diverse Monitoring Capabilities for More Concise Pre-Clinical Findings Toronto, Ontario. – March 9, 2006 – Adding to its in vivo micro-imaging leadership position VisualSonics, the world’s …